Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-038215

General Counsel and Secretary sold 3,966 shares at an average $42.67 ($169,242)

  • General Counsel and Secretary acquired 7,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KASINGER JAMES R. General Counsel and Secretary 2025-03-10 Option exercise +5,500 80,380 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-11 Sale −2,850 $42.42 $120,897 77,530 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-11 Option exercise +2,250 79,780 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-12 Sale −1,116 $43.32 $48,345 78,664 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2025-03-10 Option exercise · Restricted Stock Units −5,500 11,000 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-11 Option exercise · Restricted Stock Units −2,250 0 D
Open-market sales · 3,966 sh · avg $42.67 · $169,242
Loading xslF345X05/ownership.xml…